Lenalidomide and GM-CSF in Treating Patients With Prostate Cancer

Summary

RATIONALE: Lenalidomide may stop the growth of prostate cancer by blocking blood flow to the tumor. GM-CSF may stimulate the immune system in different ways and stop tumor cells from growing. Giving lenalidomide together with GM-CSF may kill more tumor cells. PURPOSE: This phase I/II trial is studying the side effects and best dose of lenalidomide when given together with GM-CSF and to see how well it works in treating patients with prostate cancer.

Timeline

Start

2005-07

Primary completion

2009-10

Completion

2012-12

Drugs

Indications